CTI BIOPHARMA CORP (CTIC) Stock Income Statement
NASDAQ:CTIC - Nasdaq - US12648L6011 - Common Stock - Currency: USD
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 75.77M | 53.95M | 0.00 | 0.00 | 3.35M | |||
| Minority Interest Expense | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Cost Of Goods | 4.46M | 3.51M | N/A | N/A | N/A | |||
| Gross Profit | 71.31M | 50.43M | N/A | N/A | N/A | |||
| Operating Expenses | 125.24M | 130.23M | 95.33M | 43.57M | 43.27M | |||
| Research and Development | 39.06M | 36.90M | 39.14M | 25.94M | 24.11M | |||
| Selling, General, and Administrative Expenses | 88.69M | 84.83M | 56.20M | 17.63M | 19.16M | |||
| Operating Income | -53.93M | -79.80M | -95.33M | -43.57M | -39.92M | |||
| Interest Income/Expense | -15.28M | -13.14M | -2.44M | -910.00K | -630.00K | |||
| Other Income/Expense | N/A | -56.00K | N/A | -3.77M | 1.32M | |||
| Non Recurring Items | N/A | N/A | -138.00K | -4.20M | -790.00K | |||
| Income Before Taxes | -69.24M | -92.99M | -97.91M | -52.45M | -40.02M | |||
| Net Income | -69.24M | -92.99M | -97.91M | -52.45M | -40.02M | |||
| EBITDA | -51.77M | -77.85M | -94.81M | -43.04M | -39.37M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.58 | -0.81 | -1.09 | -0.74 | -0.69 | |||
| Non GAAP EPS | -0.58 | -0.85 | -1.08 | -0.69 | -0.69 | |||
| Statistics | ||||||||
| Gross Profit Margin | 94.11% | 93.49% | N/A | N/A | N/A | |||
| Profit Margin | -91.38% | -172.37% | N/A | N/A | -1194.63% | |||
| Operating Profit Margin | -71.18% | -147.91% | N/A | N/A | -1191.64% | |||
All data in USD